Trevia®R2
Therapeutic Segment:
Anti-Diabetic
Generic Name:
Ertugliflozin + Sitagliptin
Indication
Tablet
- 5MG + 100MG
- 15MG + 100MG
Trevia®R2 (Ertugliflozin + Sitagliptin) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both Ertugliflozin and Sitagliptin is appropriate.